AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira sales drop.

There’s a lesson here for long-term leaders: When the time comes, let go. James Gorman at Morgan Stanley has definitely ...

JPMorgan Chase & Co. said it expects its 2025 net interest income to fall to about $90 billion excluding markets from its reported 2024 level of $92.4 billion. The bank said lower interest rates ...

JPMorgan Chase & Co. (NYSE: JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm ...

Markets have already been lifted by Trump's election victory and the prospect that it will mean less regulation and lower ...

Wall Street CEOs voiced confidence on Wednesday that the incoming US administration would be business-friendly and good for banks as they reported a profits surge after dealmaking and trading picked ...

At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.

Citigroup climbed 5.7 per cent and Goldman Sachs gained 5.4 per cent after both banks beat Wall Street profit forecasts. Goldman said its global banking and markets business generated nearly US$35 ...

While Biogen has made an opportunistic bid for partner Sage, its top executive seemed to play down the urgency for his ...

JPMorgan, Wells Fargo, Goldman Sachs and Citi are kicking off earnings season on Wednesday with their December-quarter ...

Wall Street breathed a sigh of relief after a surprise slowdown in inflation spurred a stock rally and a plunge in bond ...

The only danger, from Wall Street’s perspective, is that the Trump team’s MAGA instincts and chaotic approach prevent a ...